Wright Medical exited the second quarter on an impressive note with both revenues and earnings beating the Zacks Consensus Estimate. Also, strong margins and reiterated full-year outlook buoy optimism. The company is putting efforts in product innovation through research and development. Wright Medical launched INVISION Total Ankle Revision System, the first of its kind for total ankle revision arthroplasty. Furthermore, the launch of PERFORM Reversed will boost revenues in the later half of the year after the company delivers additional instrument sets to the U.S. field. On the flipside, a drop in Lower extremities sales and Upper extremities sales internationally is a concern. Over the last six months, Wright Medical has had an unimpressive run on the bourse, underperforming the broader industry. Moreover, the anticipated dis-synergies in the Lower extremities segment are likely to mar the top line in the near term.